🔗 Share this article

An underground market for unlicensed slimming medications is being driven by social media fitness personalities and vendors on communication apps, based on recent findings.

Experimental Treatment Gaining Traction Online

The experimental drug, which is still in clinical trials, is being promoted by social media influencers for its supposed weight-reducing properties. Followers are encouraged to message these profiles directly for supplier links, while also receiving discount codes.

Active Commerce on Social Networks

Separately, a robust trade exists on messaging services, where groups with thousands of members share “before and after” photos, administration instructions and assertions of next-day UK delivery. Sellers promote the substance there before redirecting customers to WhatsApp for purchases.

Understanding Retatrutide

Retatrutide is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies indicate it could help patients lose up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the successor to Ozempic.

Medical Professionals Express Worries

Nevertheless, physicians and chemists have warned that the sale of what remains an unlicensed drug in the UK is a cause for concern and could result in users administering products of unknown origin.

Several experts stated the popularity for retatrutide could be linked to the rising price of licensed weight loss products such as Mounjaro.

Regulatory Status and Enforcement

Selling retatrutide on TikTok or messaging apps is illegal in the UK, as it is an unapproved drug that must not be promoted or supplied for human use under the British medical regulations.

Some content creators try to sidestep the rules by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and supply can still breach medicines, advertising, and customer regulations, risking penalties, legal action or imprisonment.

Service Reaction and Content Removal

Based on TikTok, the platform has taken down problematic content and banned related keywords and query recommendations. The organization said it was committed to keeping the service secure and investing in enhancing enforcement strategies.

Digital Marketplace Activities

Investigations also discovered groups with up to nine thousand participants selling retatrutide using Telegram's integrated search feature, which operates like a public directory. Entering “retatrutide” instantly displays groups with thousands of users, filled with photos of weight loss, glowing testimonials and detailed guides for mixing or administering at home.

After minutes of entering one community, a vendor shared WhatsApp details, where most transactions take place. The seller sent an instruction manual and guaranteed delivery within two days. When asked whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. Not one asked about body mass, health issues or past usage.

Item Information and Pricing

Inside these communities, posts show dark colored packages with postal service stickers, claiming to contain new batches. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between powder vials, mixed at home with sterile water, or pre-filled injectors typically priced at 160 pounds for 20mg. When asked how long a injector should be used, vendors give conflicting answers varying between a several days to “depends on your body”.

Platform Oversight and Safety Actions

A spokesperson for Telegram stated it actively monitored dangerous content on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“People are administering materials they cannot confirm. Even if the science behind this drug is sound, these online products may not contain what they claim,” stated Jason Murphy, the head of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of Asda Online Doctor connected the increase in demand to recent cost increases for approved slimming drugs such as Mounjaro. “With costs increasing, patients are turning to online platforms. But counterfeit injections are extremely dangerous. You can’t be certain what’s contained or whether the conditions they were made in was sterile,” she said.

Her staff has already encountered patients injured by self-injection from unconfirmed sources. “We understand the frustration, but buying from Telegram or WhatsApp is gambling with your well-being,” stated the doctor. “These materials could be contaminated or improperly measured.”

Producer Statement

A spokesperson from the pharmaceutical company stated the substance was in third stage clinical trials and had not been reviewed or approved by any government authority globally. “Consequently at this time no one can market [it] for personal consumption,” they explained, noting that any product “misleadingly claiming itself as a Lilly experimental substance not yet approved … may subject users to possibly significant medical dangers”.